139 related articles for article (PubMed ID: 15654835)
41. Studies in immunodermatology. VI. IF studies of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic lesions.
Beutner EH; Jablonska S; Jarzabek-Chorzelska M; Marciejowska E; Rzesa G; Chorzelski TP
Int Arch Allergy Appl Immunol; 1975; 48(3):301-23. PubMed ID: 46852
[TBL] [Abstract][Full Text] [Related]
42. [Immunochemical and immunohistochemical study of calpastatin, an endogenous calpain inhibitor, in the masseter muscle of the rabbit].
Pompili E; Pantanali F; Deli R; De Renzis G
Minerva Stomatol; 1995 Sep; 44(9):397-402. PubMed ID: 8668113
[TBL] [Abstract][Full Text] [Related]
43. The detection of IgG and IgA autoantibodies to desmocollins 1-3 by enzyme-linked immunosorbent assays using baculovirus-expressed proteins, in atypical pemphigus but not in typical pemphigus.
Hisamatsu Y; Amagai M; Garrod DR; Kanzaki T; Hashimoto T
Br J Dermatol; 2004 Jul; 151(1):73-83. PubMed ID: 15270874
[TBL] [Abstract][Full Text] [Related]
44. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR
J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
[TBL] [Abstract][Full Text] [Related]
45. Increased IgA antibodies to cytokeratins in the spondyloarthropathies.
Borg AA; Nixon NB; Dawes PT; Mattey DL
Ann Rheum Dis; 1994 Jun; 53(6):391-5. PubMed ID: 7518663
[TBL] [Abstract][Full Text] [Related]
46. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance.
Gupta B; Raghav SK; Agrawal C; Chaturvedi VP; Das RH; Das HR
J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869
[TBL] [Abstract][Full Text] [Related]
47. Mycoplasma hyorhinis upregulates calpastatin and inhibits calpain-dependent proteolysis in SH-SY5Y neuroblastoma cells.
Elkind E; Rechnitzer H; Vaisid T; Kornspan JD; Barnoy S; Rottem S; Kosower NS
FEMS Microbiol Lett; 2010 Mar; 304(1):62-8. PubMed ID: 20100284
[TBL] [Abstract][Full Text] [Related]
48. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
49. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever.
Krutitskaya L; Tokarevich N; Zhebrun A; Kartseva N; Tarasevich I; Yablonskaya V; Fatalieva S; Misnikov OP; Vasilenko AZ
Acta Virol; 1996 Sep; 40(4):173-7. PubMed ID: 9014006
[TBL] [Abstract][Full Text] [Related]
50. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
51. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
[TBL] [Abstract][Full Text] [Related]
52. [The diagnostic value of platelet glycoprotein-specific autoantibody detection in autoimmune thrombocytopenic purpura].
Li W; Hou M; Zhang M; Zhu Y; Ma D
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):374-6. PubMed ID: 11877102
[TBL] [Abstract][Full Text] [Related]
53. Reduced anti-TNFalpha autoantibody levels coincide with flare in systemic lupus erythematosus.
Sjöwall C; Ernerudh J; Bengtsson AA; Sturfelt G; Skogh T
J Autoimmun; 2004 Jun; 22(4):315-23. PubMed ID: 15120755
[TBL] [Abstract][Full Text] [Related]
54. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
[TBL] [Abstract][Full Text] [Related]
55. Neuroprotective effects of Mycoplasma hyorhinis against amyloid-β-peptide toxicity in SH-SY5Y human neuroblastoma cells are mediated by calpastatin upregulation in the mycoplasma-infected cells.
Elkind E; Vaisid T; Kornspan JD; Barnoy S; Rottem S; Kosower NS
Neurochem Int; 2011 Mar; 58(4):497-503. PubMed ID: 21219955
[TBL] [Abstract][Full Text] [Related]
56. Ex vivo measurement of calpain activation in human peripheral blood lymphocytes by detection of immunoreactive products of calpastatin degradation.
Mikosik A; Zaremba A; Puchalska Z; Daca A; Smolenska Z; Lopatniuk P; Mital A; Hellman A; Bryl E; Witkowski JM
Folia Histochem Cytobiol; 2007; 45(4):343-7. PubMed ID: 18165173
[TBL] [Abstract][Full Text] [Related]
57. Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis.
El-Rachkidy RG; Young HS; Griffiths CE; Camp RD
J Invest Dermatol; 2008 Sep; 128(9):2219-24. PubMed ID: 18385761
[TBL] [Abstract][Full Text] [Related]
58. Detection of human anti-annexin autoantibodies by enzyme immunoassays.
Kraus M; Römisch J; Bastian B; Pâques EP; Hartmann AA
J Immunoassay; 1992; 13(3):411-39. PubMed ID: 1506459
[TBL] [Abstract][Full Text] [Related]
59. Domain reactivity of autoantibodies to calpastatin in patients with systemic rheumatic diseases.
Kanazawa Y; Kaneshiro Y; Sawa M; Yasuoka H; Nojima T; Ohosone Y; Mimori T
Mod Rheumatol; 2000 Mar; 10(1):38-44. PubMed ID: 24383532
[TBL] [Abstract][Full Text] [Related]
60. Development of an enzyme-linked immunosorbent assay (ELISA) for quantification of skeletal muscle calpastatin.
Doumit ME; Lonergan SM; Arbona JR; Killefer J; Koohmaraie M
J Anim Sci; 1996 Nov; 74(11):2679-86. PubMed ID: 8923182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
